ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences management will participate in a virtual investor conference with Franklin Templeton on Friday, May 29, 2026 at 10:30 AM IST. The meeting will be a one-on-one (1X1) session with Mr. Krishnakumar Vaidyanathan representing Franklin Templeton. The company has clarified that discussions will only reference publicly available documents and no unpublished price sensitive information (UPSI) will be shared during the interaction. The schedule is subject to change in case of unforeseen developments.
This is a routine regulatory disclosure under SEBI LODR regulations and does not carry any immediate price-sensitive implications. The company's explicit denial of UPSI discussion is standard compliance language intended to prevent any market speculation around the meeting.